Breaking News Bar

Business News and Information

Weird Science? Big Pharma's Top Three M&A Deals in 2009 Nears $160 Billion, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 01/11/10 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Three deals dominated the drug industry this year: Each of the companies were seeking science, or more specifically, the profitable results of that science. Pfizer Incorporated (NYSE:PFE) (New York, New York) closed its $68 billion deal to purchase Wyeth. Roche Holding Limited (OTC:RHHBY) (Basel, Switzerland) finalized its nearly $47 billion move to acquire the remainder of biotech giant Genentech and Merck & Company Incorporated (NYSE:MRK) snapped up Schering-Plough for $41 billion. The dollar numbers involved are staggering, especially in the face of the global recession. But then again, this is an industry known for its deep pockets, no matter what the economic weather.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy related markets. For more than 26 years, Industrial Info has provided plant and project opportunity databases, market forecasts, high resolution maps, and daily industry news. For more information send inquiries to or visit us at

Add to Digg Bookmark with Add to Newsvine

Joe Govreau

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear